Aulin Sherry
- SEC CIK
- 0001862144
No open-market purchases or sales filed in the past year.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.Chief Financial Officeras of Dec 19, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Aulin Sherry as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 (view filing) | Dec 18 | 1 day | Aulin SherryChief Financial Officer | SSale | −18.7K | $41.21 | −$770.9K | −100.0%0 after | 2 lots |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Aulin SherryChief Financial Officer | SSale | −15.4K | $39.57 | −$607.6K | −100.0%0 after |